Reports by quarter

Reports submitted in 2026-Q2 · page 11

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 98.90 % area, n=1009. Read the 2026-Q2 state-of-the-index report →

1,009 records26 pagesmedian on this page 98.91 %updated 30 Jul 2026

Report	Compound	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041765	MK-677 (Ibutamoren mesylate)	FGP	FGP-2604-K1470	Janoshik	2026-Q2	99.93	5.08	—	Supplier-supplied	0	FAIL
AX-2026-041747	Cagrilintide	FGP	FGP-2602-M9870	Nordanalyt	2026-Q2	98.03	3.83	—	Supplier-supplied	0	PASS
AX-2026-041527	BPC-157	QYB	QYB-2601-H6381	PeptideMeter	2026-Q2	99.93	2.96	105.3	Supplier-supplied	1	MARGINAL
AX-2026-041499	Kisspeptin-10	QYB	QYB-2512-X5662	Nordanalyt	2026-Q2	99.93	4.38	103.6	Supplier-supplied	0	PASS
AX-2026-041291	Semaglutide	WWB	WWB-2603-N3120	Nordanalyt	2026-Q2	99.33	6.56	—	Supplier-supplied	2	MARGINAL
AX-2026-043298	IGF-1 LR3	CPC	CPC-2512-S2394	Janoshik	2026-Q2	97.28	2.61	—	Supplier-supplied	0	PASS
AX-2026-042556	GHK-Cu	ERP	ERP-2601-F7633	PeptideMeter	2026-Q2	98.84	4.48	—	Supplier-supplied	0	PASS
AX-2026-042327	Tirzepatide	HJ	HJ-2605-D3120	PeptideMeter	2026-Q2	98.11	4.37	100.3	Supplier-supplied	2	MARGINAL
AX-2026-041749	Cagrilintide	FGP	FGP-2602-M9870	Janoshik	2026-Q2	99.47	4.14	—	Supplier-supplied	0	PASS
AX-2026-041620	BPC-157	QSC	QSC-2511-N8732	Medutest	2026-Q2	99.93	5.41	—	Supplier-supplied	1	MARGINAL
AX-2026-041441	Liraglutide	QYB	QYB-2511-V5143	Kestrel	2026-Q2	99.80	5.72	95.7	Supplier-supplied	0	PASS
AX-2026-041352	BPC-157	WWB	WWB-2604-B3510	Janoshik	2026-Q2	99.89	5.00	90.8	Supplier-supplied	1	MARGINAL
AX-2026-041307	Ipamorelin	WWB	WWB-2604-E3153	Medutest	2026-Q2	99.72	5.93	97.0	Supplier-supplied	1	MARGINAL
AX-2026-043276	Hexarelin	CPC	CPC-2511-F1491	Medutest	2026-Q2	98.22	5.17	—	Laboratory-retained	2	FAIL
AX-2026-043275	Hexarelin	CPC	CPC-2511-F1491	Janoshik	2026-Q2	98.77	4.43	—	Supplier-supplied	2	FAIL
AX-2026-043252	BPC-157	SGN	SGN-2512-H1950	Janoshik	2026-Q2	98.19	4.87	99.3	Buyer-sourced	2	MARGINAL
AX-2026-042961	Retatrutide	KP	KP-2604-N4308	Janoshik	2026-Q2	98.29	5.67	—	Buyer-sourced	2	MARGINAL
AX-2026-042935	Semaglutide	MKM	MKM-2601-Y3343	Kestrel	2026-Q2	98.44	3.70	—	Supplier-supplied	2	MARGINAL
AX-2026-042021	Liraglutide	TFC	TFC-2511-E6528	Kestrel	2026-Q2	99.86	3.83	—	Supplier-supplied	0	PASS
AX-2026-041821	PT-141 (Bremelanotide)	FGP	FGP-2602-Y1702	Janoshik	2026-Q2	99.42	4.15	—	Supplier-supplied	0	PASS
AX-2026-041697	Semaglutide	QSC	QSC-2604-H9231	PeptideMeter	2026-Q2	99.76	6.75	106.7	Supplier-supplied	0	PASS
AX-2026-043448	BPC-157	WXT	WXT-2602-W4680	Janoshik	2026-Q2	98.40	4.68	—	Supplier-supplied	2	MARGINAL
AX-2026-043119	Mazdutide	SSA	SSA-2605-G6781	Janoshik	2026-Q2	99.28	2.75	—	Supplier-supplied	1	MARGINAL
AX-2026-042963	Retatrutide	KP	KP-2604-N4308	Nordanalyt	2026-Q2	98.57	5.08	—	Supplier-supplied	2	MARGINAL
AX-2026-042866	BPC-157	GGPeps	GGPE-2512-G2285	Janoshik	2026-Q2	98.11	3.95	105.8	Supplier-supplied	2	MARGINAL
AX-2026-042789	Retatrutide	GGPeps	GGPE-2604-X1414	PeptideMeter	2026-Q2	97.20	5.80	99.9	Laboratory-retained	1	MARGINAL
AX-2026-042747	N-Acetyl Semax Amide	GGPeps	GGPE-2512-A1206	Janoshik	2026-Q2	98.25	7.00	—	Buyer-sourced	1	FAIL
AX-2026-042582	SLU-PP-332	GGPeps	GGPE-2511-R8569	Janoshik	2026-Q2	98.98	4.56	—	Supplier-supplied	1	MARGINAL
AX-2026-041857	ARA-290	JEEP	JEEP-2601-K3139	Kestrel	2026-Q2	99.09	4.21	—	Supplier-supplied	1	MARGINAL
AX-2026-041608	Pinealon	QSC	QSC-2602-V8219	VendorInvestigate	2026-Q2	99.93	7.95	106.0	Buyer-sourced	0	PASS
AX-2026-041308	Ipamorelin	WWB	WWB-2604-E3153	VendorInvestigate	2026-Q2	99.93	6.24	103.9	Buyer-sourced	0	PASS
AX-2026-041287	Semaglutide	WWB	WWB-2603-N3120	Nordanalyt	2026-Q2	99.04	6.47	—	Supplier-supplied	2	MARGINAL
AX-2026-043489	GHRP-2	WXT	WXT-2605-U5824	PeptideMeter	2026-Q2	98.83	5.76	96.6	Supplier-supplied	2	FAIL
AX-2026-043384	Sermorelin	CPC	CPC-2605-N3532	VendorInvestigate	2026-Q2	98.47	4.73	95.5	Buyer-sourced	1	MARGINAL
AX-2026-043183	PT-141 (Bremelanotide)	GL Biochem	GLBI-2511-F8417	Janoshik	2026-Q2	97.84	1.92	—	Supplier-supplied	2	FAIL
AX-2026-042861	Retatrutide	GGPeps	GGPE-2601-C2423	Nordanalyt	2026-Q2	97.48	4.46	—	Supplier-supplied	1	MARGINAL
AX-2026-042699	Retatrutide	GGPeps	GGPE-2512-D9394	Janoshik	2026-Q2	98.74	3.89	—	Supplier-supplied	1	MARGINAL
AX-2026-042324	Tirzepatide	HJ	HJ-2605-D3120	VendorInvestigate	2026-Q2	98.11	4.76	89.3	Buyer-sourced	3	MARGINAL
AX-2026-041607	Pinealon	QSC	QSC-2602-V8219	Janoshik	2026-Q2	99.93	7.46	—	Supplier-supplied	0	FAIL
AX-2026-041297	Semaglutide	WWB	WWB-2603-N3120	PeptideMeter	2026-Q2	99.05	6.39	96.5	Supplier-supplied	2	MARGINAL